Ai-Ling Li
alli@ncba.ac.cn
Chinese, English
Beijing
Fudan University
Basic Medical Sciences
  • 2010: National Science Fund for Distinguished Young Scholars
  • 2011: China Youth Science and Technology Award
  • 2015: Selected for the National Hundred, Thousand and Ten Thousand Talent Project
  • 2016: Selected as a Leading Talent in Scientific and Technological Innovation in the National Ten Thousand Talents Program
  • 2014: Rated as a Young and Middle-aged Leading Talent in Scientific and Technological Innovation in the National Innovative Talent Promotion Plan
  • 2017: Enjoyed special government allowances
  • National Science Fund for Distinguished Young Scholars (2010)
  • China Youth Science and Technology Award (2011)
  • Selected for the National Hundred, Thousand and Ten Thousand Talent Project (2015)
  • Selected as a Leading Talent in Scientific and Technological Innovation in the National Ten Thousand Talents Program (2016)
  • Rated as a Young and Middle-aged Leading Talent in Scientific and Technological Innovation in the National Innovative Talent Promotion Plan (2014)
  • Enjoyed special government allowances (2017)
Tumor biological behavior and its molecular regulatory mechanisms
Biomedical analysis and biosafety
  • Deactivation of IKK by CUE domain containing 2 (CUEDC2) via recruitment of the protein phosphatase PP1, Hui-Yan Li, Hui Liu, Chen-Hui Wang, Ji-Yan Zhang, Jiang-Hong Man, Yan-Fei Gao, Pei-Jing Zhang, Wei-Hua Li, Jie Zhao, Xin Pan, Tao Zhou, Wei-Li Gong, Ai-Ling Li and Xue-Min Zhang, 2008
  • CUEDC2 modulates cardiomyocytes oxidative capacity by regulating GPX1 stability, Zhao Jian, Bing Liang, Xin Pan, Guang Xu, Sai-Sai Guo, Ting Li, Tao Zhou, Ying-Bin Xiao, and Ai-Ling Li, 2016
  • Induction of SOX4 by DNA damage is critical for p53 stabilization and function, Xin Pan, Jie Zhao, Wei-Na Zhang, Hui-Yan Li, Rui Mu, Tao Zhou, Hai-Ying Zhang, Wei-Li Gong, Ming Yu, Jiang-Hong Man, Pei-Jing Zhang, Ai-Ling Li and Xue-Min Zhang, 2009
  • Autosomal dominant retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced mitophagy through regulating ULK1 mRNA splicing, Guang Xu, Ting Li, Jiayi Chen, Changyan Li, Haixin Zhao, Chengcheng Yao, Hua Dong, Kaiqing Wen, Kai Wang, Jie Zhao, Qing Xia, Tao Zhou, Huafeng Zhang, Ping Gao, Ailing Li and Xin Pan, 2018
  • Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex–mediated STAT1 downregulation, Xiaoyan Zhan, Saisai Guo, Yuanyuan Li, Haowen Ran, Haohao Huang, Lanjuan Mi, Jin Wu, Xinzheng Wang, Dake Xiao, Lishu Chen, Da Li, Songyang Zhang, Xu Yan, Yu Yu, Tingting Li, Qiuying Han, Kun He, Jiuwei Cui, Tao Li, Tao Zhou, Jeremy N. Rich, Shideng Bao, Xuemin Zhang, Ailing Li, and Jianghong Man, 2020
  • MAVS O-GlcNAcylation Is Essential for Host Antiviral Immunity against Lethal RNA Viruses, Song N, Qi Q, Cao R, Qin B, Wang B, Wang Y, Zhao L, Li W, Du X, Liu F, Yan Y, Yi W, Jiang H, Li T, Zhou T, Li HY, Xia Q, Zhang XM, Zhong W, Li AL, Duan X, 2019
  • FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer, Lingyu Li, Wei Li, Naifei Chen, Haixin Zhao, Guang Xu, Yijing Zhao, XinPan, Xiaoying Zhang, Lei Zhou, Dehai Yu, Ailing Li, Ji-Fan Hu, Jiuwei Cui, 2019
  • CUE domain containing protein-2 promotes the Warburg effect and tumorigenesis, Xiuying Zhong, Shengya Tian, Xiang Zhang, XinweiDiao, Fangting Dong, Jie Yang, Zhaoyong Li, Linchong Sun, Lin Wang, Xiaoping He, Gongwei Wu, Xin Hu, Lihua Wang, Libing Song, Huafeng Zhang, Xin Pan, Ailing Li, Ping Gao, 2017
  • Tumor-targeted delivery of biologically active TRAIL protein, Hai-Ying Zhang, Jiang-Hong Man, Bing Liang, Tao Zhou, Chen-Hui Wang, Tao Li, Hui-Yan Li, Wei-Hua Li, Bao-Feng Jin, Pei-Jing Zhang, Jie Zhao, Xin Pan, Kun He, Wei-Li Gong, Xue-Min Zhang, and Ai-Ling Li, 2010
  • Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis, Na Wang, Yuan Cao, Wei Song, Kun He, Tao Li, Jie Wang, Bin Xu, Hai-yan Si, Cheng-Jin Hu, Ai-Ling Li, 2014
Tumor Biology Molecular Regulation Cancer Research Oncology Cell Signaling Gene Expression Protein Interactions Therapeutic Targets Biomarkers Tumor Microenvironment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.